S116: DONOR-DERIVED CD5 CAR T CELLS FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

por Pan, Jing, Tan, Yue, Deng, Biping, Ling, Zhuojun, Xu, Jinlong, Duan, Jiajia, Wang, Zelin, Wang, Kai, Hu, Guang
Publicado 2023

Ruxolitinib mitigates steroid‐refractory CRS during CAR T therapy

por Pan, Jing, Deng, Biping, Ling, Zhuojun, Song, Weiliang, Xu, Jinlong, Duan, Jiajia, Wang, Zelin, Chang, Alex H., Feng, Xiaoming, Tan, Yue
Publicado 2020

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

por An, Lihong, Lin, Yuehui, Deng, Biping, Yin, Zhichao, Zhao, Defeng, Ling, Zhuojun, Wu, Tong, Zhao, Yongqiang, Chang, Alex H., Tong, Chunrong, Liu, Shuangyou
Publicado 2022

Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia

por Liu, Shuangyou, Deng, Biping, Yin, Zhichao, Pan, Jing, Lin, Yuehui, Ling, Zhuojun, Wu, Tong, Chen, Dong, Chang, Alex H., Gao, Zhiyong, Song, Yanzhi, Zhao, Yongqiang, Tong, Chunrong
Publicado 2020

Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL

por Meng, Yuan, Deng, Biping, Rong, Luan, Li, Chuo, Song, Weiliang, Ling, Zhuojun, Xu, Jinlong, Duan, Jiajia, Wang, Zelin, Chang, Alex H., Feng, Xiaoming, Xiong, Xiujuan, Chen, Xiaoli, Pan, Jing
Publicado 2021

Corrigendum: Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL

por Meng, Yuan, Deng, Biping, Rong, Luan, Li, Chuo, Song, Weiliang, Ling, Zhuojun, Xu, Jinlong, Duan, Jiajia, Wang, Zelin, Chang, Alex H., Feng, Xiaoming, Xiong, Xiujuan, Chen, Xiaoli, Pan, Jing
Publicado 2021

A novel full-human CD22-CAR T cell therapy with potent activity against CD22(low) B-ALL

por Tan, Yue, Cai, Haodong, Li, Chuo, Deng, Biping, Song, Weiliang, Ling, Zhuojun, Hu, Guang, Yang, Yongkun, Niu, Panpan, Meng, Guangrong, Cheng, Wei, Xu, Jinlong, Duan, Jiajia, Wang, Zelin, Yu, Xinjian, Feng, Xiaoming, Zhou, Jianfeng, Pan, Jing
Publicado 2021

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia

por Tan, Yue, Shan, Lingling, Zhao, Liping, Deng, Biping, Ling, Zhuojun, Zhang, Yanlei, Peng, Shuixiu, Xu, Jinlong, Duan, Jiajia, Wang, Zelin, Yu, Xinjian, Zheng, Qinlong, Xu, Xiuwen, Tian, Zhenglong, Zhang, Yibing, Zhang, Jiecheng, Chang, Alex H., Feng, Xiaoming, Pan, Jing
Publicado 2023